A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT07657052 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG: XH-S003 Capsule

Sponsor

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.